Group 1 - IDEX Biometrics ASA has reported primary insider transactions involving key executives [1] - The transactions include notifications from Morten Opstad, Chairman, and Anders Storbraten, CEO [2] - The information is disclosed in compliance with EU Market Abuse Regulation and Norwegian Securities Trading Act [1]

Core Points - IDEX Biometrics ASA held an Extraordinary General Meeting on 11 April 2025, where all proposed resolutions were approved [1] - The company announced a share consolidation with a ratio of 100 old shares for 1 new share [1] - The last day to include the right to the old shares is 10 June 2025, with the ex-date set for 11 June 2025 and the record date for 12 June 2025 [1] - A new ISIN will be assigned to the company's shares, changing from NO0013107490 to NO0013536078, effective 11 June 2025 [1] Company Overview - IDEX Biometrics ASA is a global leader in fingerprint biometrics, providing authentication solutions for payments, access control, and digital identity [2] - The company's biometric solutions are built on patented sensor technologies and target card-based applications for payments and digital authentication [2] - IDEX partners with leading card manufacturers and technology companies to bring its solutions to market [2]

Core Viewpoint - IDEX Biometrics ASA held an extraordinary general meeting on April 11, 2025, where all proposed resolutions were passed, including share capital reduction and share consolidation [1][2]. Group 1: Meeting Outcomes - A total of 268,077,252 shares, representing 32.24% of the capital, were present at the extraordinary general meeting [1]. - The share consolidation will occur at a ratio of one hundred shares into one, expected to take effect around June 11, 2025 [2]. - Following the share capital reduction and issuance of new shares, the company's share capital will be NOK 38,315,942.32, divided into 3,831,594,232 shares, each with a nominal value of NOK 0.01 [3]. Group 2: Company Information - IDEX Biometrics ASA is a global leader in fingerprint biometrics, providing authentication solutions for payments, access control, and digital identity [3]. - The company focuses on card-based applications for payments and digital authentication, partnering with leading card manufacturers and technology companies [3].

Company Overview - IDEX Biometrics ASA is a global technology leader in fingerprint biometrics, providing authentication solutions for payments, access control, and digital identity [2] - The company's biometric solutions are built on patented sensor technologies, integrated circuit designs, and software, targeting card-based applications for payments and digital authentication [2] - IDEX partners with leading card manufacturers and technology companies to bring its solutions to market, enhancing convenience, security, and user experience [2] Shareholder Information - As of 9 April 2025, Morten Opstad, chair of the board, holds 265,382,308 shares, representing 31.9% of the share capital and voting rights in IDEX Biometrics [1]

At the close of business on 07 April 2025, Morten Opstad, chair of the board of IDEX Biometrics, held the following voting rights in IDEX, for the extraordinary general meeting on 11 April 2025. Total 142,779,329 shares or 17.17% of the share capital and votes, including shares held by Mr. Opstad and close relations. Some of the proxies may include voting instructions. Contact personsMarianne Bøe, Head of Investor Relations, Tel.: +47 918 00186Kristian Flaten, CFO, Tel.: +47 950 92322E-mail: ir@idexbiome ...

NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA, THE HONG KONG SPECIAL ADMINISTRATIVE REGION OF THE PEOPLE'S REPUBLIC OF CHINA OR JAPAN OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL. OTHER RESTRICTIONS ARE APPLICABLE. PLEASE SEE THE IMPORTANT NOTICE AT THE END OF THIS STOCK EXCHANGE ANNOUNCEMENT. Oslo, Norway – 31 March 2025 - Reference is made to the stock exchange announcements from IDEX Biometrics ASA (the "Compan ...

At the close of business on 31 March 2025, Morten Opstad, chair of the board of IDEX Biometrics, held the following voting rights in IDEX, for the extraordinary general meeting on 11 April 2025. Total 63,760,705 shares or 7.37% of the share capital and votes, including shares held by Mr. Opstad and close relations. Some of the proxies may include voting instructions. Contact persons Marianne Bøe, Head of Investor Relations, Tel.: +47 918 00186 Kristian Flaten, CFO, Tel.: +47 950 92322 E-mail: ir@idexbiometr ...

Reference is made to the announcement by IDEX Biometrics ASA on 18 March 2025 regarding the results of the exercise of Warrants A. A total of 17,258 Warrants A were exercised, resulting in an aggregate subscription for 17,258 new shares, each Warrant A having an exercise price of NOK 0.15. The share capital increase has been registered in the Norwegian Register of Business Enterprises. Following the issue, IDEX Biometrics ASA share capital is NOK 124,739,134.80, divided into 831,594,232 shares, each with a ...

IDEX Biometrics ASA (“IDEX” or “Company”) released its preliminary financial statements for 2024 on 27 February 2025. Subsequently, on 11 March 2025, the Company announced its revised business strategy plan. The Company has reviewed its assets and business in view of this strategy. Certain equipment items have been written down and an obsolescence provision has been recognised on inventory, and other, minor adjustments have been made. The total effect for the IDEX Biometrics group on the consolidated result ...

IDEX Biometrics ASA will hold an extraordinary general meeting (“EGM”) on Friday 11 April 2025 at 12.00 CET as an online meeting. Reference is made to the announcement by IDEX Biometrics ASA (the "Company") on 11 March 2025 regarding the loan financing of NOK 30 million secured, proposed debt conversion, and amendment of Convertible Bond. The EGM-notice and the interim statement of financial position are attached. Shareholders may attend online by PC, smartphone or tablet. There is no physical attendance op ...